{
  "paper_metadata": {
    "pmid": "37067535",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the BRCA2 c.7847C>T (p.Ser2616Phe) variant, its clinical significance, penetrance data, and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7847C>T",
      "protein_notation": "p.Ser2616Phe",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Japanese patients",
        "phenotype": "breast or ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "III-3",
          "age_at_evaluation": 59,
          "age_at_onset": null,
          "age_at_diagnosis": 59,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal carcinoma of the left breast",
          "evidence_sentence": "In Family 1, the proband (III\u20103) was a 59\u2010year\u2010old Japanese woman who was diagnosed with invasive ductal carcinoma of the left breast."
        },
        {
          "individual_id": "III-6",
          "age_at_evaluation": 49,
          "age_at_onset": null,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal carcinoma of the right breast",
          "evidence_sentence": "Subsequently, her maternal cousin (III\u20106), who also had a history of invasive ductal carcinoma of the right breast, which was positive for estrogen receptor and negative for progesterone receptor and HER2, at the age of 49 years, underwent BRCA1/2 genetic testing and was found to carry the same BRCA2 variant."
        },
        {
          "individual_id": "II-2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 65,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer (high-grade serous carcinoma)",
          "evidence_sentence": "Notably, the proband's mother (II\u20102) and the cousin's mother (II\u20104), who were sisters, had died of ovarian cancer (high-grade serous carcinoma) at the ages of 65 and 72 years, respectively."
        },
        {
          "individual_id": "II-4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 72,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer (high-grade serous carcinoma)",
          "evidence_sentence": "Notably, the proband's mother (II\u20102) and the cousin's mother (II\u20104), who were sisters, had died of ovarian cancer (high-grade serous carcinoma) at the ages of 65 and 72 years, respectively."
        },
        {
          "individual_id": "III-1",
          "age_at_evaluation": 55,
          "age_at_onset": 48,
          "age_at_diagnosis": 48,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal carcinoma of the right breast",
          "evidence_sentence": "In Family 2, the proband (III\u20101) was a 55\u2010year-old Japanese woman who developed invasive ductal carcinoma of the right breast at the age of 48 years."
        },
        {
          "individual_id": "II-14",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 67,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "liver cancer",
          "evidence_sentence": "Genetic testing revealed that she also carried the same BRCA2 variant."
        },
        {
          "individual_id": "III-2",
          "age_at_evaluation": 37,
          "age_at_onset": null,
          "age_at_diagnosis": 37,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "In Family 3, a Japanese woman (III\u20101) with a history of triple\u2010negative breast cancer at the age of 52 years harbored the BRCA1 c.188T>A (p.Leu63Ter) and BRCA2 c.7847C>T (p.Ser2616Phe) variants."
        },
        {
          "individual_id": "II-1",
          "age_at_evaluation": 59,
          "age_at_onset": null,
          "age_at_diagnosis": 59,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "pancreatic cancer",
          "evidence_sentence": "Her father (II\u20101) developed pancreatic cancer at the age of 59 years."
        },
        {
          "individual_id": "III-9",
          "age_at_evaluation": 47,
          "age_at_onset": null,
          "age_at_diagnosis": 47,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Another notable family history was that the proband's maternal grandmother (I\u20104) and maternal cousin (III\u20109) developed breast cancer at the ages of 54 and 47 years, respectively, although genetic testing was not conducted for them."
        },
        {
          "individual_id": "II-1",
          "age_at_evaluation": 35,
          "age_at_onset": null,
          "age_at_diagnosis": 35,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "In Family 4, a Japanese woman (II\u20101) who developed breast cancer positive for estrogen receptor and negative for progesterone receptor and HER2 at the age of 35 years had the BRCA2 c.7847C>T (p.Ser2616Phe) variant."
        },
        {
          "individual_id": "II-1",
          "age_at_evaluation": 53,
          "age_at_onset": null,
          "age_at_diagnosis": 53,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer (high-grade serous carcinoma)",
          "evidence_sentence": "In Family 5, a 53-year-old Japanese woman (II\u20101) developed ovarian cancer (high-grade serous carcinoma) and was found to carry the BRCA2 c.7847C>T (p.Ser2616Phe) variant."
        }
      ],
      "functional_data": {
        "summary": "The functional assays indicated that the BRCA2 c.7847C>T (p.Ser2616Phe) variant has deleterious effects.",
        "assays": [
          "MANO-B method",
          "ABCD test"
        ]
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": "Not registered in gnomAD, TopMed, and HGVD; found in ToMMo 38KJPN with an allele frequency of 1.03\u00d710\u22124.",
      "evidence_level": "Moderate evidence for pathogenicity based on cosegregation analysis and functional assays.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was classified as a VUS before this study reclassified it as likely pathogenic.",
      "key_quotes": [
        "This variant recurs only in families from Japan and has not been reported in the global general population databases.",
        "The clinical features of the variant carriers were not specific to, but were consistent with, those of patients with hereditary breast and ovarian cancer."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}